Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Revenue

In the year 2025, Bukwang Pharmaceutical had annual revenue of 200.71B KRW with 25.38% growth. Bukwang Pharmaceutical had revenue of 62.51B in the quarter ending December 31, 2025, with 35.37% growth.

• Revenue: 200.71B
• Revenue Growth: +25.38%
• P/S Ratio: 3.58
• Revenue / Employee: 326.36M
• Employees: 615
• Market Cap: 718.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	200.71B	40.63B	25.38%
Dec 31, 2024	160.09B	34.16B	27.13%
Dec 31, 2023	125.93B	-64.98B	-34.04%
Dec 31, 2022	190.91B	8.42B	4.61%
Dec 31, 2021	182.49B	12.83B	7.56%